Copan Newlab’s commitment to safer therapies

Innovation in the pharmaceutical industry goes beyond creating improved drugs; it also includes guaranteeing the safety of these products for patients. Today, we are excited to announce the launch of PharmaLab™, the fully automated platform aimed at transforming the processes of pharmaceutical Quality Control laboratories worldwide.

Why PharmaLab™?

PharmaLab™ represents a groundbreaking advancement in QC laboratory automation, providing a comprehensive solution for the entire quality control workflow – from plate handling and incubation to image analysis and reporting – built upon Copan’s decade-long expertise in clinical microbiology automation.

PharmaLab™ cutting-edge artificial intelligence, advanced hardware, and user-friendly functionality make it an indispensable asset for modern laboratories:

• Enhanced Data Integrity
• Increased Efficiency
• Improved Accuracy
• Cost Savings
• Scalability

Implementing PharmaLab™ is not just investing in a product – it means embracing a smarter, faster, and more efficient future for pharmaceutical Quality Control processes, avoiding costly recalls, and ensuring the safety of patients.

Discover more on the PharmaLab™ page, and contact us for more information:

Here are the top articles from March 2025 showcasing our products:

• The first study evaluated the performance of the Xpert® Carba-R assay, a real-time PCR-based test for detecting carbapenemase (CPE) genes directly from rectal swabs using the FecalSwab™ collection device. The Italian researchers found that 200 μL of the FecalSwab™ sample medium provided reliable Ct values with fewer invalid samples than traditional methods, with a detection limit for the CPE genes ranging from 4.7 × 10³ to 6.8 × 10³ CFU/mL. Storage conditions were also evaluated, revealing improved performance at room temperature after 16 hours compared to storage at 4 °C. The study concluded that FecalSwab™ could enhance CPE screening by facilitating both molecular and cultural methods with a single sampling.
• Prof Cristino and her team are the authors of the second study proposing an environmental SARS-CoV-2 surface routine monitoring approach for a rapid and effective evaluation of surface hygienic conditions and the effectiveness of sanitization measures. The researchers collected surface samples using SRK® and compared three molecular techniques: Reverse Transcription Loop-mediated isothermal AMPlification (RT-LAMP,), Reverse-Transcription quantitative polymerase chain reaction (RT-qPCR), and droplet digital PCR (ddPCR). Considering the overall properties of each technique, this study suggests using RT-LAMP as an effective method to screen negative from positive surfaces. In the event of a positive outcome, a sensitive, quantitative test such as ddPCR should be used to confirm the result.
• The third study is a collaboration between the US and Switzerland aimed at identifying the optimal processing method for tongue swabs in the Xpert Ultra assay for detecting pulmonary tuberculosis (TB). Four methods utilizing Xpert Sample Reagent (SR) combined with varying concentrations of Tris–EDTA–Tween were compared against treatment with SR alone and a standard heat inactivation protocol. Swabs from volunteers without TB were placed in test buffers spiked with known amounts of Mycobacterium tuberculosis to evaluate the performance of each method, indicating that swabs processed with a 1:1 diluted SR buffer had the lowest detection limit. While these findings highlight the potential of optimized tongue swab processing methods, this research emphasizes the importance of refining sample preparation techniques to enhance the sensitivity and reliability of TB diagnostics using tongue swabs.

Read the full studies below:

In an exclusive interview, Patrick Wirth, CEO of BAMOS AG—a leading Swiss laboratory specializing in microbiological and physicochemical analysis—shared insights into the transformative impact of the Cyclone automation system on the company’s operations.

Set for excellence

In the interview, Patrick Wirth discussed how Cyclone streamlined workflows while maintaining the high-quality standards BAMOS AG is known for. Moreover, he explained how Copan Newlab’s automation for microbiology quality control reduced human error and enhanced process consistency.

As BAMOS AG continues to expand its service portfolio and embrace technological advancements, Patrick remains optimistic about the future of laboratory testing and food safety. “Automation is not just about saving time; it’s about raising standards and staying ahead of industry challenges,” he concluded.

With tools like Cyclone paving the way, BAMOS AG is set to lead the change in delivering state-of-the-art analytics for the food and dairy industries.

Download and read the full interview!